Protease - Activated Receptor - 4, PAR - 4 Agonist, amide, human incorporates the minimal activation motif tailored to human PAR-4. Amidation at the C-terminus enhances stability and receptor engagement in biochemical assays. Sequence architecture supports studies on protease cleavage specificity. Researchers use it to dissect early signaling events and conformational changes in PAR-4 pathways.
CAT No: T05037
Synonyms/Alias:Protease - Activated Receptor - 4, PAR - 4 Agonist, amide, human;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More